Dr. Vandana S. Shashi

My practice includes caring for children and adults with inherited conditions, such as inherited disorders of metabolism, genetic syndromes, mitochondrial disorders, inherited causes of growth failure or developmental delay, and conditions detected by newborn screening. My clinic works with the Pediatric Biochemical Genetics Laboratory to diagnose these conditions. We provide treatment for inherited disorders of metabolism. I work closely with the geneticists, neurologists, pediatricians, internists, and other providers at Duke University Medical Center to provide comprehensive care for my patients. My research has been aimed at developing new treatments for inherited conditions, focusing on glycogen storage diseases, like Pompe disease and von Gierke disease. We have developed gene therapy for these conditions and are in the process of starting clinical trials to test safety and benefits. Dr. Koeberl is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Pompe Disease, Von Gierke Disease, Propionic Acidemia, and X-Linked Creatine Deficiency. Dr. Koeberl is board certified in American Board Of Medical Genetics, Clinical Biochemical Genetics , American Board Of Medical Genetics, Clinical Genetics And Genomics - General , and American Board Of Pediatrics, General Pediatrics. Dr. Koeberl is currently accepting new patients.

Priya Kishnani is a Pediatrics provider practicing medicine in Durham, North Carolina. Dr. Kishnani is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Pompe Disease, Glycogen Storage Disease Type 3, Hypophosphatasia (HPP), Glycogen Storage Disease Type 9, and Splenectomy. Dr. Kishnani is currently accepting new patients.

I am an academic adult and pediatric neuro-oncologist who helps lead The Preston Robert Tisch Brain Tumor Center at Duke. I am the author of more than 500 peer-reviewed articles, reviews, and book chapters, and I have presented extensively at both international and national meetings. I am a committed educator who is a member of the executive and super-executive committees of the Duke University School of Medicine, which are responsible for the recruitment, screening and selection of medical students. I have reviewed grants for the National Institutes of Health for over 15 years, in a spectrum of different study sections. I am the senior editor of CNS Oncology and a reviewer for over 25 academic journals. I serve on the advisory board of a number of organizations, including Voices Against Brain Cancer, the Tug McGraw Foundation, Pinnacle Care, the Pediatric Brain Tumor Foundation, the National Children’s Cancer Society, and the American Brain Tumor Association. Dr. Friedman is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, and Brain Tumor. Dr. Friedman is board certified in American Board Of Pediatrics, General Pediatrics and American Board Of Pediatrics, Pediatric Hematology-Oncology. Dr. Friedman is currently accepting new patients.